Company
SingaporeGlaxo Wellcome Manufacturing Pte Limited, Singapore, Singapore – FDA Inspections
Inspection records and compliance data for Glaxo Wellcome Manufacturing Pte Limited in Singapore. 6 FDA inspections on record, 1 Form 483, last inspected October 13, 2023.
Company Profile
This profile covers Glaxo Wellcome Manufacturing Pte Limited based in Singapore, Singapore.
FDA Inspection History
- FDA inspections
- 6
- OAI
- 0
- VAI
- 2
- NAI
- 4
- Form 483s
- 1
- Warning letters
- 0
First inspected March 13, 2009. Last inspected October 13, 2023.
FDA inspections (6)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| October 13, 2023 | VAI | Human Drugs · Drug Quality Assurance | 1275331 |
| September 2, 2022 | NAI | Human Drugs · Drug Quality Assurance | 1191253 |
| June 1, 2018 | VAI | Human Drugs · Drug Quality Assurance | 1055375 |
| January 16, 2014 | NAI | Human Drugs · Drug Quality Assurance | 865559 |
| November 16, 2012 | NAI | Human Drugs · Drug Quality Assurance | 807638 |
| March 13, 2009 | NAI | Human Drugs · Drug Quality Assurance | 572094 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Glaxo Wellcome Manufacturing Pte Limited
FEI Number
3002807079
Address
Pioneer Sector 1, Singapore, Singapore
Country
Singapore
ID: 5bc5ffcf-9696-4708-86c1-f63fb5a0fc28